| 摘要 |
An IC card used for linking components of a health care transaction to results from a biomarker measurement, test or procedure, including an algorithmic-real time calculation of optimized therapy choice(s) is provided. The on-card, dynamic processing capabilities of the card can facilitate payment, selection and/or reimbursement authorization of drug, biologic or medical devices as a result of biomarker findings in order to optimize benefits and/or mitigate the risks of therapy. The card may be employed for risk mitigation strategies by coding for safety biomarker results that trigger immediate point-of-dispensation re-evaluation or discontinuation of product. |
